Barrett Robert J, Caul William F, Smith Randy
Veterans Administration Medical Center, Departments of Psychology, Vanderbilt University, 1310 24th Avenue South, Nashville, TN 37212-2637, USA.
Pharmacol Biochem Behav. 2005 May;81(1):1-8. doi: 10.1016/j.pbb.2004.12.012. Epub 2005 Apr 22.
In the present experiment rats were trained on a three-lever, drug-discrimination task to discriminate the cues associated with 0.30 mg/kg of the indirect dopamine (DA) agonist, amphetamine (AMPH), saline (SAL), and 0.03 mg/kg of the DA, D2 receptor antagonist, haloperidol (HAL). Choice behavior determined from tests on 0.30 and 0.15 mg/kg AMPH, SAL 0.03 and 0.015 mg/kg HAL provided a behavioral baseline presumed to represent changes along a continuum of DA mediated, interoceptive cues. Results from separate groups tested on 0.30 and 0.15 mg/kg AMPH, SAL, 0.03 and 0.015 mg/kg HAL, 24 h post-treatment with an acute 7.5 mg/kg dose of AMPH, showed rapid tolerance and withdrawal to the AMPH cue and sensitization to the HAL cue. The same tests 24 h following treatment with 1.0 mg/kg HAL showed rapid tolerance to the HAL cue, sensitization to the AMPH cue, but not AMPH-like withdrawal cues. Analysis of the results showed that tolerance to the AMPH and HAL cues reflected neuroadaptive baseline shifts and not weaker cue properties. These findings are consistent with predictions from opponent process theory of motivation and provide an animal model to study the motivational consequences that aversive symptoms of AMPH withdrawal such as dysphoria and anhedonia can have on drug-taking behavior.
在本实验中,对大鼠进行了一项三杠杆药物辨别任务训练,以辨别与0.30毫克/千克间接多巴胺(DA)激动剂苯丙胺(AMPH)、生理盐水(SAL)以及0.03毫克/千克DA、D2受体拮抗剂氟哌啶醇(HAL)相关的线索。根据对0.30和0.15毫克/千克AMPH、SAL以及0.03和0.015毫克/千克HAL的测试所确定的选择行为,提供了一个行为基线,假定其代表了沿DA介导的内感受性线索连续体的变化。对分别接受0.30和0.15毫克/千克AMPH、SAL、0.03和0.015毫克/千克HAL测试的不同组进行的实验结果显示,在急性给予7.5毫克/千克剂量的AMPH治疗24小时后,对AMPH线索出现快速耐受和戒断,而对HAL线索出现敏化。在用1.0毫克/千克HAL治疗24小时后的相同测试显示,对HAL线索出现快速耐受,对AMPH线索出现敏化,但未出现类似AMPH的戒断线索。结果分析表明,对AMPH和HAL线索的耐受反映了神经适应性基线变化,而非较弱的线索特性。这些发现与动机的对手过程理论的预测一致,并提供了一个动物模型来研究AMPH戒断的厌恶症状(如烦躁不安和快感缺失)对药物摄取行为可能产生的动机后果。